scispace - formally typeset
Z

Zhixiang Zhou

Researcher at Beijing University of Technology

Publications -  29
Citations -  946

Zhixiang Zhou is an academic researcher from Beijing University of Technology. The author has contributed to research in topics: Fusion gene & Cancer. The author has an hindex of 11, co-authored 27 publications receiving 731 citations.

Papers
More filters
Journal ArticleDOI

Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.

TL;DR: The obtained data suggest that co-delivery of DOX and miR-34a could achieve synergistic effects on tumor suppression and nanosystem-based co-Delivery of tumor suppressive miRNAs and chemotherapeutic agents may be a promising combined therapeutic strategy for enhanced anti-tumor therapy.
Journal ArticleDOI

MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer.

TL;DR: It is shown that overexpression of miR-203 in esophageal cancer cells dramatically increased cell apoptosis and inhibited cell proliferation, migration and invasion as well as tumor growth and down-regulated miR -21 expression, and small GTPase Ran was a target gene of mi R-203.
Journal ArticleDOI

Transcriptomic Analyses of the Biological Effects of Airborne PM2.5 Exposure on Human Bronchial Epithelial Cells

TL;DR: Human bronchial epithelial cells exposed to various concentrations of particles smaller than 2.5 μm collected from Beijing, China induced a large number of genes involved in responses to xenobtiotic stimuli, metabolic response, and inflammatory and immune response pathways, which might contribute to PM2.5-related pulmonary diseases.
Journal ArticleDOI

Degradable Hyaluronic Acid/Protamine Sulfate Interpolyelectrolyte Complexes as miRNA-Delivery Nanocapsules for Triple-Negative Breast Cancer Therapy

TL;DR: In vitro and in vivo experiments illustrate that HP‐IPECs have a great potential as a biodegradable vector for microRNA‐based therapy against triple‐negative breast cancer.
Journal ArticleDOI

Chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells in type I collagen-hydrogel for cartilage engineering.

TL;DR: Collagen hydrogel can provide an appropriate 3-D environment for the chondrogenesis of UC-MSCs, which possess the capacity to differentiate along osteogenic lineage and have great potential for cartilage engineering.